Wird geladen...
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis
INTRODUCTION: Sugammadex is used for the reversal of neuromuscular blockade caused by rocuronium bromide and vecuronium bromide. As part of the post licensing phase of drug development, adverse events related to the use of sugammadex are still being uncovered and being reported. The potential associ...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Drug Saf |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700844/ https://ncbi.nlm.nih.gov/pubmed/31452867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098619869077 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|